Future Market Insights (FMI) positions healing skin care products as a dermo-cosmetic and OTC-adjacent category where growth will be governed by three control points: tighter cosmetics compliance and in-market surveillance, the scale-up of dermatology-partnered distribution models, and portfolio capital allocation by global beauty and consumer health leaders into skin barrier, sensitive-skin, and repair platforms. The category’s growth quality will be defined by operators that will be able to substantiate repair claims within cosmetics rules, maintain pharmacy-led credibility, and expand clinically anchored brands across omnichannel routes.